≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Hyperosmolality and hypernatraemia

EFO MESH Endpoint Browser PheWeb

E4_HYPEROSMHNAT

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E87.0
  • Hospital discharge: ICD-9 — 2760
  • Cause of death: ICD-10 — E87.0
  • Cause of death: ICD-9 — 2760

2 out of 7 registries used, show all original rules.

468

4. Check minimum number of events

None

468

5. Include endpoints

None

468

6. Filter based on genotype QC (FinnGen only)

468

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E87
Name in latin
Hyperosmolalitas

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6622 3751 2831
Only index persons 5696 3249 2447
Unadjusted period prevalence (%)
Whole population 0.09 0.11 0.08
Only index persons 0.11 0.12 0.09
Median age at first event (years)
Whole population 77.28 80.01 73.68
Only index persons 77.45 80.17 73.85

-FinnGen-

Key figures

All Female Male
Number of individuals 468 214 254
Unadjusted period prevalence (%) 0.09 0.07 0.11
Median age at first event (years) 71.36 71.22 71.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
424
Matched controls
4238
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
4503599627370496.0
323.0
421
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
135.5
99.1
103
10
E86
ICD-10 Finland
Volume depletion
164.0
55.3
57
*
E87.6
ICD-10 Finland
Hypokalaemia
45.3
42.7
52
13
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.6
36.7
153
460
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.4
28.9
191
822
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
28.7
127
391
AA1AD
NOMESCO Finland
CT of head and brain
3.5
28.3
169
670
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.6
28.0
76
135
N05AX08
ATC
risperidone; systemic
5.3
27.8
93
214
N05AA02
ATC
levomepromazine; systemic
9.3
26.3
56
68
N05AH03
ATC
olanzapine; systemic
8.0
25.5
60
86
N03AG01
ATC
valproic acid; systemic, rectal
7.5
25.2
62
95
R53
ICD-10 Finland
Malaise and fatigue
3.4
24.7
145
555
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.1
24.6
109
330
N05AN01
ATC
lithium; oral
15.6
24.4
40
28
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
21.8
97
292
N05AH04
ATC
quetiapine; oral
3.8
21.8
105
339
E87.5
ICD-10 Finland
Hyperkalaemia
63.4
21.1
24
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.7
20.8
101
327
N05BA04
ATC
oxazepam; oral
3.0
20.5
146
626
A06AD11
ATC
lactulose; oral
3.3
20.5
123
469
A28
ICPC
Limited function/disability NOS
3.3
20.0
119
449
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.9
19.5
148
658
N17.9
ICD-10 Finland
Acute renal failure, unspecified
7.9
19.1
44
61
E23.2
ICD-10 Finland
Diabetes insipidus
73.3
18.9
21
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.7
18.7
177
897
R41.0
ICD-10 Finland
Disorientation, unspecified
6.5
18.5
49
83
L28
ICPC
Limited function/disability (L)
3.2
18.3
112
430
G72.8
ICD-10 Finland
Other specified myopathies
13.9
17.7
30
23
C03CA01
ATC
furosemide; systemic
2.5
17.7
194
1061
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.8
17.2
40
56
102
Kela drug reimbursment
Diabetes insipidus
66.1
16.9
19
*
103
Kela drug reimbursment
Diabetes, insulin-treated
2.6
16.9
156
769
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
12.3
16.8
30
26
N05BA06
ATC
lorazepam; systemic, sublingual
5.3
16.8
53
112
N05AF03
ATC
chlorprothixene; systemic
11.4
16.7
31
29
N05CD07
ATC
temazepam; oral
3.2
16.7
100
374
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
6.2
16.6
45
79
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.2
16.4
52
110
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.5
16.1
59
146
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
12.9
16.1
28
23
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.7
15.7
46
89
H02AB09
ATC
hydrocortisone; systemic
15.5
15.5
25
17
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.9
15.5
68
199
N06AB04
ATC
citalopram; systemic
2.8
15.5
115
494
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.7
15.3
70
213
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.4
15.0
81
277
N05AX12
ATC
aripiprazole; systemic
11.0
14.9
28
27
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
58.8
14.9
17
*
N05AA01
ATC
chlorpromazine; systemic, rectal
20.9
13.9
20
10
E23.00
ICD-10 Finland
Panhypopituitarism
77.7
13.7
15
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
7.1
13.6
33
50
SPAT1234
SPAT
Support of social functional capacity
4.6
13.5
48
115
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
19.0
13.5
20
11
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
19.0
13.5
20
11
SPAT1254
SPAT
Administration of medicine
2.8
13.3
93
382
I50.9
ICD-10 Finland
Heart failure, unspecified
2.7
13.1
105
468
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
7.0
13.1
32
49
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.5
13.0
120
577
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.8
12.9
32
50
N25.1
ICD-10 Finland
Nephrogenic diabetes insipidus
+∞
12.6
12
*
A10AE04
ATC
insulin glargine; parenteral
3.5
12.5
61
195
A10BA02
ATC
metformin; oral
2.3
12.2
148
812
N05AH02
ATC
clozapine; systemic
12.9
12.2
21
17
N05BA01
ATC
diazepam; systemic, rectal
2.9
12.1
80
315
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
22.1
12.1
17
8
F20.9
ICD-10 Finland
Schizophrenia, unspecified
9.3
11.9
24
27
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
15.2
11.9
19
13
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.8
11.8
51
147
F10.25
ICD-10 Finland
Alcohol dependence continuous use
11.0
11.4
21
20
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
11.3
92
408
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.2
11.3
43
111
N30.0
ICD-10 Finland
Acute cystitis
2.9
11.2
74
289
R50.9
ICD-10 Finland
Fever, unspecified
2.9
11.2
74
291
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
11.2
83
349
N03AX09
ATC
lamotrigine; oral
7.0
11.2
27
41
N05AC02
ATC
thioridazine; oral
7.7
11.1
25
34
P20
ICPC
Memory disturbance
2.7
11.1
84
360
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
4.3
11.1
41
103
A04
ICPC
Weakness/tiredness general
2.9
11.0
73
285
N03AF02
ATC
oxcarbazepine; oral
8.1
11.0
24
31
E83.50
ICD-10 Finland
Hypercalcemia
44.5
11.0
13
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
10.8
84
362
N05AB03
ATC
perphenazine; systemic, rectal
5.5
10.7
31
60
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.3
10.5
53
174
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.3
10.5
27
45
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.4
10.3
50
159
A41.9
ICD-10 Finland
Sepsis, unspecified
4.9
10.2
33
72
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
13.6
10.2
17
13
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
7.2
10.2
24
35
N05AD01
ATC
haloperidol; systemic
5.0
10.2
32
68
F03
ICD-10 Finland
Unspecified dementia
3.8
10.1
43
123
N04AA02
ATC
biperiden; systemic
7.9
10.0
22
29
N06AX11
ATC
mirtazapine; oral
2.1
10.0
140
806
N05AF05
ATC
zuclopenthixol; systemic
12.6
9.9
17
14
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
9.7
90
425
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
8.1
9.7
21
27
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
9.4
9.6
19
21
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.3
9.6
49
162
N06DX01
ATC
memantine; oral
3.0
9.4
57
211
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
9.4
61
237
G30.1
ICD-10 Finland
Alzheimer disease with late onset
3.0
9.4
55
201
N03AF01
ATC
carbamazepine; oral, rectal
4.0
9.2
36
96
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
10.4
9.1
17
17
C07AB07
ATC
bisoprolol; oral
1.9
9.1
225
1594
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
9.0
55
204
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.8
9.0
38
108
A10BH01
ATC
sitagliptin; oral
3.0
9.0
53
194
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
24.6
9.0
12
5
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
8.9
39
115
R11
ICD-10 Finland
Nausea and vomiting
3.1
8.9
50
177
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
11.0
8.9
16
15
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
8.8
269
2034
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
51.0
8.7
10
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.1
8.7
33
86
101
Kela drug reimbursment
Anterior pituitary hypofunction
16.7
8.6
13
8
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
8.6
76
349
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
8.5
41
130
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
28.1
8.5
11
*
E87.8
ICD-10 Finland
Other disorders of electrolyte and fluid balance, not elsewhere classified
91.8
8.4
9
*
F05.9
ICD-10 Finland
Delirium, unspecified
5.7
8.4
23
42
SPAT1263
SPAT
Sampling
1.9
8.3
178
1183
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
9.7
8.3
16
17
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.3
8.3
19
27
SPAT1262
SPAT
Handing over of treatment supplies
2.2
8.3
90
459
C08CA01
ATC
amlodipine; oral
1.9
8.3
175
1162
N05CF01
ATC
zopiclone; oral
1.9
8.2
154
978
I50.0
ICD-10 Finland
Congestive heart failure
2.7
8.2
55
219
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
8.1
45
157
SPAT1216
SPAT
Assessment of functional ability
2.2
8.0
84
423
P99
ICPC
Psychological disorders other
8.0
7.9
17
22
R33
ICD-10 Finland
Retention of urine
2.8
7.9
53
209
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
7.9
59
248
F31.2
ICD-10 Finland
Bipolar affective disorder, current episode manic with psychotic symptoms
45.8
7.7
9
*
R55
ICD-10 Finland
Syncope and collapse
2.5
7.7
63
278
AA400
NOMESCO Finland
Electroconvulsive therapy
18.8
7.6
11
6
F31
ICD-10 Finland
Bipolar affective disorder
18.8
7.6
11
6
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
25.5
7.6
10
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
9.1
7.6
15
17
188
Kela drug reimbursment
Psychosis requiring demanding treatment
10.3
7.6
14
14
N06AB03
ATC
fluoxetine; oral
2.7
7.6
54
221
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
7.5
33
98
N05BA02
ATC
chlordiazepoxide; systemic
5.8
7.5
20
36
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
81.4
7.4
8
*
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
13.7
7.4
12
9
E87.2
ICD-10 Finland
Acidosis
+∞
7.3
7
*
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
16.1
7.3
11
7
N03AX14
ATC
levetiracetam; systemic
5.5
7.2
20
38
SPAT1301
SPAT
No procedures
1.8
7.2
146
943
29570
ICD-8 Finland
Schizophrenia, Schizo-affective type
20.4
7.2
10
5
P29
ICPC
Psychological sympt/compl other
4.5
7.1
24
56
Y94.0
ICD-10 Finland
Accident at home
5.8
7.1
19
34
K59.09
ICD-10 Finland
Constipation, unspecified
3.3
7.1
34
108
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
7.1
32
97
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
9.0
7.1
14
16
F10.24
ICD-10 Finland
Alcohol depence active use
10.3
7.1
13
13
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
10.3
7.1
13
13
N06AA12
ATC
doxepin; systemic
3.1
7.0
37
127
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
5.6
7.0
19
35
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.7
7.0
15
20
H02AA02
ATC
fludrocortisone; oral
9.5
6.8
13
14
A10AE05
ATC
insulin detemir; parenteral
3.5
6.8
30
90
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
6.7
124
775
S06.0
ICD-10 Finland
Concussion
2.5
6.7
50
213
S97
ICPC
Chronic ulcer skin
3.2
6.6
33
109
J01EA01
ATC
trimethoprim; systemic
1.9
6.6
111
669
N06AB06
ATC
sertraline; oral
2.7
6.6
45
180
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
6.6
111
673
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.5
127
803
N30.9
ICD-10 Finland
Cystitis, unspecified
3.2
6.5
33
110
A10BH05
ATC
linagliptin; oral
3.3
6.5
31
99
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.8
6.5
20
43
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.4
63
307
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.7
6.4
15
23
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
3.3
6.4
30
95
N06AX16
ATC
venlafaxine; oral
2.5
6.4
48
205
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
6.4
56
259
UKC02
NOMESCO Finland
Cystoscopy
2.0
6.3
80
435
E000001
ATC
NA
2.0
6.3
89
505
E83.51
ICD-10 Finland
Hypocalcemia
+∞
6.3
6
*
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.4
6.2
15
24
T90
ICPC
Diabetes non-insulin dependent
1.9
6.2
97
570
N05BE01
ATC
buspirone; oral
4.4
6.2
21
50
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
6.2
76
408
N07BB01
ATC
disulfiram; oral
4.8
6.2
19
41
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
6.2
36
737
SPAT1229
SPAT
Assessment of need for aid
2.5
6.1
47
203
N02BE01
ATC
paracetamol; systemic, rectal
1.8
6.1
343
2953
P16
ICPC
Acute alcohol abuse
8.8
6.1
12
14
WX872
NOMESCO Finland
Intensive care
3.2
6.0
29
94
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
6.0
76
410

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003181) Sodium [Moles/volume] in Urine
91
39
28.72
129.85
2.2
1.4
mmol/l
66.8
62.4
0.26
80
32
(3008295) Osmolality of Serum or Plasma
59
31
21.63
76.60
2.7
2.0
mosm/kgh2o
304.7
280.8
3.24
48
21
(3036481) Cortisol [Moles/volume] in Serum or Plasma
107
252
5.21
44.17
2.5
2.0
nmol/l
363.3
370.5
0.12
100
227
(3023183) Ammonium ion [Moles/volume] in Plasma
56
76
8.23
39.88
2.0
3.6
umol/l
29.3
41.4
1.47
47
60
(3026782) Osmolality of Urine
187
721
3.65
39.19
3.6
2.7
mosm/kgh2o
500.7
565.1
2.90
169
610
(3012095) Magnesium [Moles/volume] in Serum or Plasma
146
509
3.72
35.16
5.7
3.3
mmol/l
0.8
0.8
0.80
141
476
(3009466) Valproate [Moles/volume] in Serum or Plasma
41
46
9.67
33.82
8.2
4.2
umol/l
376.3
355.9
0.30
33
39
(3002032) Base excess in Venous blood by calculation
110
329
4.06
32.87
4.8
3.6
mmol/l
2.7
2.2
0.62
97
257
(3023368) Bacteria identified in Blood by Culture
219
1061
3.00
29.66
6.6
3.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
111
409
3.25
23.58
8.3
6.3
mmol/l
1.5
1.5
0.03
93
305
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
204
1046
2.68
23.53
4.0
2.0
u/l
319.7
308.1
0.04
194
971
(3009343) pH of Capillary blood
78
246
3.60
21.06
4.8
4.1
ph
7.4
7.4
0.09
15
24
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
75
231
3.68
20.98
4.8
4.3
mmol/l
2.3
2.1
0.13
57
185
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
136
605
2.76
20.31
2.3
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
107
431
2.92
19.15
8.7
5.3
mmol/l
107.0
104.2
1.54
100
424
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
197
1075
2.44
19.00
3.5
2.3
u/l
56.1
58.2
0.27
186
983
(3024561) Albumin [Mass/volume] in Serum or Plasma
255
1561
2.39
18.93
6.2
4.1
g/l
31.2
34.7
12.02
234
1422
(3015235) Bicarbonate [Moles/volume] in Capillary blood
45
103
4.73
18.68
3.8
2.4
mmol/l
24.1
25.3
0.45
40
80
(3000991) Gas panel - Venous blood
79
273
3.28
18.38
8.5
7.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
25
33
7.95
17.99
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
207
1183
2.34
17.67
4.7
3.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
303
2064
2.33
16.70
10.5
4.2
mmol/l
7.4
6.8
3.76
295
1927
(3004789) Transferrin [Mass/volume] in Serum or Plasma
114
507
2.65
16.69
2.1
2.1
g/l
2.2
2.3
0.75
104
462
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
277
1819
2.28
16.65
11.9
5.7
mmol/l
1.2
1.2
0.04
232
1527
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
277
1826
2.27
16.40
6.5
6.0
umol/l
11.5
12.2
0.40
260
1721
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
73
258
3.17
16.29
2.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
73
261
3.13
15.96
6.1
4.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
55
165
3.64
15.87
2.3
1.8
ug/l
12.0
3.4
0.61
48
140
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
31
62
5.28
14.99
1.5
1.5
mmol/l
4.7
3.8
2.20
31
56
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
332
2.82
14.81
1.9
2.2
g/l
0.2
0.2
0.12
75
305
(3032080) INR in Blood by Coagulation assay
239
1531
2.15
14.62
10.0
10.5
inr
1.3
1.3
0.00
75
402
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
96
421
2.61
14.29
2.2
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
149
809
2.23
13.70
2.2
1.7
nmol/l
1331.8
1166.9
0.93
118
603
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
250
1659
2.09
13.61
11.2
5.2
mmol/l
1.2
1.2
0.80
231
1478
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
21
32
6.82
13.30
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
114
566
2.34
12.87
2.2
2.1
umol/l
10.5
12.6
2.84
104
525
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
92
417
2.50
12.69
2.1
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
162
934
2.12
12.63
2.6
2.1
mg/l
3.1
3.4
0.83
143
793
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
102
486
2.40
12.62
2.2
2.1
%
20.2
22.1
0.54
82
412
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
66
255
2.85
12.48
3.3
3.3
ng/l
84.0
84.6
0.02
51
217
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
19
28
7.03
12.39
1.2
1.1
pmol/l
193.1
284.2
0.79
11
23
(1616796) Gas panel - Central venous blood
30
69
4.58
12.34
5.8
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
30
70
4.51
12.12
3.6
2.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
140
777
2.14
11.94
3.5
2.4
e6/l
6.5
5.1
0.79
127
680
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
216
1432
1.94
11.06
6.8
3.6
ng/l
144.2
38.6
0.76
190
1092
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
19
34
5.78
10.30
1.3
1.2
nmol/l
—
—
—
0
0
(3010421) pH of Blood
32
90
3.74
10.11
7.4
3.3
ph
7.4
7.4
0.15
25
70
(3027945) Reticulocytes/100 erythrocytes in Blood
91
452
2.26
10.07
2.5
2.6
%
1.9
1.8
0.37
79
404
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
161
994
1.94
9.95
4.1
3.1
u/l
38.4
34.4
0.43
153
940
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
35
107
3.45
9.78
1.3
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
45
162
2.97
9.63
11.4
9.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
200
1341
1.86
9.50
4.0
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
138
820
1.97
9.47
1.8
1.7
pmol/l
488.1
444.3
0.92
112
665
(40767503) Oxygen content in Capillary blood by calculation
26
66
4.11
9.45
4.2
2.0
%
14.4
15.0
0.25
15
31
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
72
337
2.34
9.12
3.7
2.3
ug/l
8.4
6.7
0.37
58
290
(3002582) Erythrocytes [#/volume] in Urine
172
1130
1.83
8.51
4.2
3.1
e6/l
83.1
128.5
0.32
154
876
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
13
8.64
8.49
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
37
5.02
8.43
1.3
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
26
72
3.76
8.40
6.5
3.6
mmol/l
3.8
2.6
0.86
20
45
(3018418) pH of Serum or Plasma
163
1065
1.81
8.14
6.6
3.4
ph
7.4
7.4
0.65
41
203
(3044290) Cell count panel - Cerebral spinal fluid
21
51
4.26
8.08
1.3
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
53
228
2.49
8.06
2.0
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
79
406
2.14
7.95
2.4
4.4
u/l
242.9
237.7
0.13
69
387
(3031040) Bacteria [#/volume] in Urine by Automated count
302
2369
1.77
7.91
7.8
4.7
e6/l
2521.8
4344.1
0.26
12
37
(3020891) Body temperature
41
157
2.77
7.85
8.2
4.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
78
406
2.11
7.58
2.6
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
131
2.89
7.57
2.9
2.8
pmol/l
4.1
4.4
0.64
28
113
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
195
1367
1.73
7.51
2.7
2.1
nmol/l
76.7
79.1
0.48
171
1179
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
26
79
3.43
7.35
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
26
79
3.43
7.35
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
115
693
1.87
7.35
1.8
1.7
mg/l
1.7
1.4
0.61
91
531
(3023520) Reticulocytes [#/volume] in Blood
66
328
2.18
7.21
2.2
3.0
e9/l
70.1
68.5
0.15
55
262
(3034860) Kappa light chains.free [Mass/volume] in Serum
32
112
2.99
7.21
1.3
3.4
mg/l
65.9
107.0
0.32
26
89
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
112
2.99
7.21
1.3
3.4
mg/l
41.3
34.2
0.45
26
91
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
13
7.84
7.14
1.1
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
29
98
3.09
6.93
1.5
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
192
1367
1.69
6.82
3.0
2.4
ug/l
157.1
142.4
0.38
177
1230
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
72
378
2.07
6.82
6.5
3.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
26
83
3.26
6.82
1.2
3.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
64
322
2.14
6.77
2.6
2.4
g/l
63.7
66.3
1.26
59
288
(3015377) Calcium [Moles/volume] in Serum or Plasma
174
1210
1.70
6.73
3.4
3.0
mmol/l
2.3
2.3
1.30
152
1022
(3033705) Calcium.ionized [Moles/volume] in Venous blood
20
54
3.82
6.71
2.8
2.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
95
555
1.89
6.63
23.4
26.4
inr
1.3
1.4
0.24
17
72
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
173
1209
1.68
6.53
3.5
3.0
ng/l
2628.8
1821.4
0.54
154
1032
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
693
1.81
6.50
5.6
3.4
ng/l
157.1
332.3
0.95
92
581
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
33
4.66
6.50
1.3
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
183
1300
1.67
6.48
4.8
3.4
e6/l
275.0
150.1
0.35
158
938
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
98
2.98
6.32
3.2
3.1
u/ml
0.3
0.3
0.03
20
56
(44790047)
18
48
3.86
6.14
1.7
1.4
—
—
—
0
0
(44790049)
18
48
3.86
6.14
1.7
1.4
—
—
—
0
0
(44790048)
18
48
3.86
6.14
1.7
1.4
—
—
—
0
0
(44806118)
18
48
3.86
6.14
1.7
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
45
204
2.33
6.11
3.2
2.5
e6/l
0.3
0.4
0.54
45
198
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
16
6.36
5.98
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
96
2.92
5.94
1.6
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
85
3.05
5.93
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
80
3.11
5.89
1.5
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
42
188
2.36
5.87
5.9
4.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
202
1499
1.61
5.87
8.5
5.6
%
0.5
0.6
2.55
186
1388
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
252
1975
1.60
5.80
4.8
3.1
u/l
69.6
51.5
1.73
234
1806
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
321
2668
1.65
5.78
9.7
7.1
u/l
91.6
79.3
2.88
301
2454
(3023410) Appearance of Cerebral spinal fluid
12
24
5.11
5.77
1.3
1.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
207
1562
1.58
5.51
8.8
5.6
%
62.3
57.9
4.14
190
1455
(36304419) Bacteria [Presence] in Urine
142
978
1.65
5.51
4.1
2.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
206
1553
1.58
5.50
9.6
6.0
%
7.9
8.9
4.91
189
1445
(3013115) Eosinophils [#/volume] in Blood
221
1696
1.57
5.45
9.2
5.8
e9/l
0.2
0.2
0.61
206
1485
(1761482) Bacteria [#/volume] in Urine by Culture
30
119
2.63
5.40
5.3
5.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
44
210
2.21
5.31
11.9
7.8
%
92.4
94.2
0.62
44
210
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
180
1325
1.58
5.27
6.4
4.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
44
3.73
5.25
3.1
2.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
147
1033
1.62
5.22
4.1
2.9
e6/l
0.7
0.6
0.27
133
786
(3006315) Basophils [#/volume] in Blood
215
1653
1.56
5.18
8.6
5.5
e9/l
0.0
0.0
1.55
200
1422
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
65
364
1.91
5.11
3.0
3.2
umol/l
7.5
8.9
0.36
55
318
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
10
19
5.36
5.06
2.7
1.4
umol/l
473.2
41.0
—
5
12
(3019198) Lymphocytes [#/volume] in Blood
217
1681
1.54
5.00
8.8
5.6
e9/l
1.9
2.0
0.30
203
1471
(3001604) Monocytes [#/volume] in Blood
213
1644
1.54
4.99
8.7
5.5
e9/l
0.6
0.6
0.02
197
1406
(3002030) Lymphocytes/100 leukocytes in Blood
206
1582
1.54
4.91
9.4
5.9
%
23.0
26.7
3.81
189
1453
(3006504) Eosinophils/100 leukocytes in Blood
202
1545
1.54
4.91
8.9
5.6
%
2.4
2.9
1.75
186
1427
(3013650) Neutrophils [#/volume] in Blood by Automated count
242
1927
1.53
4.87
14.6
8.6
e9/l
5.1
4.2
3.26
223
1695
(3025941) Bacteria identified in Stool by Culture
34
151
2.35
4.86
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
293
2433
1.55
4.85
6.9
4.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
214
1671
1.52
4.65
8.0
5.3
estimate
0.0
0.0
0.00
49
320
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
135
2.39
4.63
2.1
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
34
155
2.29
4.59
6.8
5.1
mmol/l
24.7
25.2
0.40
34
150
(40760892) CBC W Ordered Manual Differential panel - Blood
101
665
1.66
4.58
4.9
4.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
11
8.32
4.58
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
215
1686
1.51
4.55
5.9
3.9
estimate
0.0
0.0
0.00
48
330
(3016018) Differential panel - Cerebral spinal fluid
10
21
4.84
4.55
1.2
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
65
3.00
4.49
2.0
2.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
71
2.90
4.44
1.8
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
215
1692
1.50
4.44
6.0
4.0
estimate
0.0
0.0
0.50
47
318
(3042936) Bacteria identified in Isolate by Culture
82
526
1.68
4.09
3.1
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
42
3.41
4.07
1.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
53
3.09
4.00
1.8
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
28
4.00
4.00
1.2
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
94
2.52
3.94
1.7
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
65
2.84
3.90
1.7
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
126
909
1.53
3.84
6.2
3.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
52
298
1.84
3.82
2.4
1.9
%
1.9
1.6
0.98
39
259
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
154
2.16
3.82
2.2
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
149
1116
1.49
3.79
8.4
5.6
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
8
8.86
3.78
1.7
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
143
1065
1.49
3.73
4.1
3.7
mg/mmol
17.3
7.5
0.74
100
656
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
194
1542
1.44
3.60
2.6
2.0
pmol/l
94.5
95.8
0.13
96
784
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
80
2.57
3.59
1.5
1.4
ug/g
172.0
295.2
2.36
11
51
(3021960) Folate [Moles/volume] in Serum or Plasma
128
939
1.50
3.58
1.8
1.5
nmol/l
18.0
20.4
0.98
116
770
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
17
5.38
3.52
1.0
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
194
1547
1.43
3.51
5.0
4.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
31
3.61
3.50
1.2
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
294
3319
0.69
3.49
5.3
4.9
mmol/l
2.3
2.7
12.49
265
2956
(3037756) Immunofixation for Serum or Plasma
22
94
2.41
3.46
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
139
1045
1.47
3.42
3.5
2.9
mmol/l
5.7
7.3
5.70
118
858
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
48
2.98
3.32
2.7
3.2
—
765.2
—
0
9
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
54
2.84
3.28
1.6
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
54
2.84
3.28
2.7
3.3
%
58.3
61.1
0.27
15
54
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
11
6.44
3.19
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
283
3197
0.71
3.18
4.8
4.3
mmol/l
1.4
1.5
3.88
258
2843
(3044640) Blood type and Crossmatch panel - Blood
140
1070
1.44
3.13
3.3
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
107
777
1.49
3.11
6.4
4.4
kg/l
1.0
1.0
0.75
21
113
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
287
3227
0.71
3.06
4.9
4.4
mmol/l
4.1
4.6
11.72
262
2904
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
32
169
1.96
3.03
1.3
1.9
g/l
1.8
1.5
0.85
26
149
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
5
10.09
2.98
2.2
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
70
2.48
2.91
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
46
277
1.73
2.90
1.7
2.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
22
4.15
2.89
1.1
1.1
mmol/l
2.3
1.9
—
9
22
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
100
727
1.48
2.88
3.4
3.1
mmol/l
2.5
2.5
0.46
84
624
(3012516) Albumin [Mass/volume] in Urine
131
1003
1.43
2.87
3.4
3.0
mg/l
842.1
333.0
0.43
94
633
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
71
2.45
2.83
1.7
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
18
4.50
2.80
4.1
3.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
18
4.50
2.80
4.9
2.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
6
8.41
2.75
1.6
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
6
8.41
2.75
1.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
14
5.06
2.73
1.0
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
67
2.44
2.66
3.3
4.5
—
529.4
—
0
11
(3029937) Albumin [Presence] in Urine by Test strip
127
980
1.41
2.64
6.4
4.1
estimate
0.0
0.0
0.00
44
312
(3039443) Prostate specific Ag panel - Serum or Plasma
0
70
0.00
2.61
0.0
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
15
4.72
2.60
1.1
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
109
821
1.43
2.60
9.4
6.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
799
0.63
2.58
2.3
3.1
ug/l
0.7
0.8
0.36
36
560
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
50
2.65
2.55
3.5
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
21
3.86
2.47
2.5
2.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
21
3.86
2.47
1.3
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
51
2.59
2.46
2.2
2.9
e9/l
4.5
4.8
0.18
13
51
(3026493) Urate [Moles/volume] in Serum or Plasma
115
884
1.40
2.43
2.7
2.7
umol/l
387.2
7231.1
3.99
97
731
(3028707) Methadone [Presence] in Urine by Screen method
10
34
2.98
2.42
3.7
2.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
45
284
1.65
2.42
3.2
4.6
%
0.9
0.9
0.04
19
95
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
139
1.92
2.41
4.3
3.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
8
6.30
2.37
1.4
3.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
8
6.30
2.37
1.8
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
8
6.30
2.37
1.4
3.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
22
3.68
2.37
1.3
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
105
800
1.40
2.33
6.5
3.8
%
80.5
85.6
1.09
99
783
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
13
4.66
2.28
1.5
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
305
1.60
2.27
6.5
3.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
18
3.93
2.26
1.3
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
9
5.60
2.22
1.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
36
2.82
2.21
1.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
48
2.54
2.20
2.3
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
14
4.33
2.15
1.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
14
4.33
2.15
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
50
334
1.56
2.15
4.0
3.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
278
2471
1.31
2.13
5.3
3.5
pmol/l
15.0
15.0
0.04
249
2187
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
10
37
2.74
2.11
1.4
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
43
2.60
2.11
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
82
2.11
2.09
2.4
2.1
ug/min
49.3
75.1
0.28
12
42
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
147
1.81
2.07
1.9
2.1
g/l
3.7
3.7
0.04
15
108
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
147
1.81
2.07
1.9
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
147
1.81
2.07
1.9
2.1
g/l
8.6
7.5
1.33
15
110
(3024263) Appearance of Synovial fluid
7
20
3.54
2.06
1.7
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
321
1.55
2.06
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
281
3096
0.77
2.03
4.5
3.9
mmol/l
1.4
1.2
2.02
257
2733
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
63
2.26
2.03
1.4
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
44
290
1.57
2.01
1.4
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
21
3.37
1.97
1.4
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
64
2.22
1.96
1.1
1.2
—
—
—
0
0
(4062490)
8
27
3.00
1.94
1.4
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
27
3.00
1.94
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
45
2.48
1.94
1.8
2.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
58
2.28
1.92
2.1
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
52
2.34
1.89
1.4
3.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
22
3.21
1.88
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
38
247
1.59
1.85
5.3
3.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
33
207
1.64
1.85
5.2
4.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
40
2.53
1.84
4.1
2.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
17
3.56
1.84
1.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
53
372
1.48
1.84
1.7
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
29
2.79
1.80
1.9
2.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
29
2.79
1.80
1.1
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
40
267
1.54
1.75
3.1
4.8
%
0.1
0.2
0.19
17
86
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
54
2.25
1.75
1.3
1.3
u/ml
347.9
311.5
—
7
31
(3016879) Cocaine [Presence] in Urine
12
54
2.25
1.75
3.3
2.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
18
3.36
1.75
2.7
3.4
nmol/l
75.7
84.8
—
6
18
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
36
2.53
1.75
1.9
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
36
2.53
1.75
1.9
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
36
2.53
1.75
1.9
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
35
227
1.59
1.73
1.9
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
55
2.21
1.68
3.4
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
55
2.21
1.68
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
97
1.89
1.68
1.5
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
31
2.61
1.66
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
38
255
1.53
1.64
3.6
4.5
%
0.8
0.5
0.28
14
71
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
98
1.87
1.64
1.5
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
17
91
1.90
1.62
2.1
1.6
iu/ml
20.0
0.2
—
7
14
(3028300) Cannabinoids [Presence] in Urine
12
56
2.17
1.62
3.4
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
56
2.17
1.62
3.4
2.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
14
3.60
1.62
1.6
1.2
nmol/l
0.1
0.2
—
5
9
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
298
0.55
1.61
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
43
2.35
1.61
1.1
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
43
2.35
1.61
1.8
2.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
13
63
2.09
1.61
2.4
3.9
%
0.6
1.1
—
8
52
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
101
811
1.31
1.59
3.4
2.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
99
1.85
1.59
1.5
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
7
26
2.72
1.58
1.1
2.8
e9/l
1.0
1.0
—
7
11
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
360
3369
1.30
1.58
35.7
15.0
mg/l
32.1
26.6
2.25
340
2702
(40768804) Tissue Pathology biopsy report
107
1296
0.77
1.54
1.9
2.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
189
1650
1.24
1.51
3.5
2.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
42
294
1.47
1.50
2.8
2.3
u/l
46.0
33.4
0.32
36
246
(3027456) Digoxin [Moles/volume] in Serum or Plasma
20
117
1.74
1.47
2.8
3.1
nmol/l
0.7
0.9
1.03
14
90
(3013512) EKG study
132
1110
1.26
1.45
5.0
3.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
52
2.14
1.45
1.6
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
6
22
2.75
1.44
1.5
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
53
2.10
1.39
1.8
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
17
2.96
1.36
1.4
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
75
1.89
1.35
1.6
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
201
1.53
1.33
2.3
2.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
43
2.11
1.31
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
94
771
1.27
1.27
4.9
4.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
36
2.24
1.25
2.1
2.5
nmol/l
5.4
3.4
—
8
36
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
25
2.42
1.24
1.0
1.5
u/ml
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
25
2.42
1.24
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
56
1.99
1.23
3.7
2.2
—
—
—
0
0
(4306422)
6
26
2.32
1.19
1.2
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
249
1.44
1.19
3.6
4.8
%
0.1
0.2
0.25
12
72
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
73
589
1.28
1.13
3.6
2.8
e6/l
2.6
2.3
0.16
53
333
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
60
472
1.31
1.12
17.6
7.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
67
828
0.78
1.12
2.0
1.6
mmol/l
1.6
1.3
1.12
56
672
(40768806) Pleura Pathology biopsy report
10
51
1.98
1.12
1.1
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
73
1.80
1.12
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
50
383
1.34
1.12
6.3
3.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
136
1.57
1.10
1.2
1.2
iu/ml
44.9
135.8
—
8
54
(3037522) Nuclear Ab [Titer] in Serum
51
393
1.33
1.10
1.3
1.4
titre
440.0
429.6
—
6
92
(3017569) Oxygen content in Arterial blood
5
21
2.40
1.09
1.4
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
41
1.97
1.09
1.1
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
359
0.68
1.08
1.7
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
472
0.72
1.07
3.5
4.4
%
33.4
31.7
0.28
23
313
(3044927) Protein electrophoresis panel - Urine
9
46
1.97
1.04
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
297
3152
0.84
1.01
32.1
13.7
ml/min/173m2
73.8
74.6
0.21
251
2597
(3012441) Differential panel - Pleural fluid
9
49
1.85
0.99
1.1
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
50
1.82
0.97
2.7
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
50
1.82
0.97
2.3
4.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
70
578
1.25
0.91
1.5
1.4
g/l
3.0
2.8
0.29
44
323
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
11
63
1.76
0.91
1.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
42
1.92
0.89
1.1
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
46
1.75
0.83
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
73
1.66
0.82
1.4
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
18
122
1.49
0.81
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
139
1.46
0.80
1.5
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
84
975
0.83
0.80
3.8
2.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
482
0.77
0.80
1.4
1.3
u/ml
18.9
14.8
0.13
18
171
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
82
1.60
0.79
2.6
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
140
1.45
0.78
2.1
2.2
g/l
3.2
3.2
0.01
15
110
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
319
3036
1.16
0.77
6.2
4.3
mu/l
1.7
2.0
3.92
283
2694
(3019230) Fractional oxyhemoglobin in Venous blood
9
54
1.68
0.75
2.0
2.1
%
52.0
62.9
—
9
54
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
38
1.85
0.74
1.1
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
267
2516
1.14
0.72
4.6
4.1
mm/h
19.7
14.0
4.50
244
2296
(3051651) Icteric interference index of Serum or Plasma
5
26
1.93
0.71
5.4
2.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
52
431
1.23
0.68
1.4
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
293
0.74
0.67
1.5
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
71
1.56
0.62
1.1
1.0
—
17.1
—
0
6
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
71
1.56
0.62
1.6
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
49
1.64
0.62
4.4
2.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
314
3268
0.88
0.62
5.5
4.7
mmol/l
6.4
6.0
3.32
274
2901
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
98
1096
0.87
0.60
3.6
4.6
%
22.7
21.6
0.28
49
593
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
72
625
1.18
0.60
3.5
2.7
e6/l
1.2
1.2
0.01
51
366
(1617658) Protocol used for examination of sentinel lymph nodes
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
140
1.37
0.59
1.3
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
81
1.49
0.57
1.1
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
194
1.30
0.57
1.4
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
36
1.68
0.57
2.7
3.3
u/ml
43.8
41.6
—
6
36
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
301
3128
0.89
0.53
8.9
5.9
mmol/mol
43.6
40.4
4.54
280
2833
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
40
1.51
0.51
1.2
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
367
3566
1.14
0.51
45.8
17.4
mmol/l
4.0
4.0
1.16
360
3449
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.50
2.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
72
637
1.15
0.49
1.3
1.2
u/ml
3.4
1.5
0.35
18
151
(3019550) Sodium [Moles/volume] in Serum or Plasma
366
3559
1.13
0.49
47.3
17.3
mmol/l
140.1
139.7
0.65
358
3442
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
48
1.47
0.47
1.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
32
384
0.82
0.46
1.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
49
1.43
0.46
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
49
1.43
0.46
1.0
1.4
—
—
—
0
0
(3000492) Spirometry study
21
264
0.79
0.46
2.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
50
1.41
0.45
1.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
50
1.41
0.45
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
50
1.41
0.45
1.0
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
157
1.29
0.44
1.3
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
31
1.62
0.43
1.2
1.0
—
2.6
—
0
12
(3037121) Protein [Mass/volume] in Urine
19
149
1.29
0.42
1.8
2.9
g/l
0.1
0.2
1.18
11
58
(4146454)
5
32
1.57
0.42
1.0
2.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
44
507
0.85
0.42
1.3
1.3
iu/ml
14.6
43.1
—
10
156
(3044941) Cell count panel - Synovial fluid
8
58
1.39
0.41
2.0
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(4024509)
5
33
1.52
0.41
2.4
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(4015189)
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
157
1474
1.10
0.41
19.1
9.6
e9/l
0.0
0.0
0.94
143
1201
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
34
1.48
0.40
3.6
3.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
106
1.33
0.39
1.4
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
40
345
1.17
0.39
2.3
2.0
ug/g
195.4
136.0
0.32
28
262
(3044889) 12 lead EKG panel
230
2399
0.92
0.39
5.5
4.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
80
1.38
0.38
2.0
1.6
mg/l
15.2
12.5
0.32
11
72
(4035726)
34
290
1.19
0.38
1.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
168
0.77
0.36
1.2
1.3
—
51.5
—
0
10
(3045142) Bone marrow Pathology biopsy report
6
43
1.40
0.35
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
15
189
0.79
0.35
2.1
2.5
—
14.6
—
0
7
(3017732) Neutrophils [#/volume] in Blood
26
219
1.20
0.33
11.7
2.9
e9/l
5.1
3.9
0.92
16
154
(3003327) Ova and parasites identified in Stool by Light microscopy
10
74
1.36
0.32
1.2
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
47
1.28
0.32
1.7
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
390
1.14
0.32
2.9
4.0
ug/l
19.8
37.3
0.32
37
330
(1002224) Polysomnography panel
7
96
0.73
0.31
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
43
382
1.14
0.30
1.7
1.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
279
2712
1.07
0.29
46.1
19.6
g/l
328.4
331.7
5.61
274
2679
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
62
1.30
0.28
1.1
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
182
0.82
0.27
1.1
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
114
1.24
0.25
4.8
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
38
419
0.90
0.22
1.4
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
42
1.19
0.21
5.6
3.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.8
—
2.6
—
0
6
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
104
0.77
0.21
1.5
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
12
0.00
0.21
0.0
1.2
—
8.2
—
0
12
(44813793)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
937.1
—
0
13
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
48
1.25
0.20
1.5
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
352
3568
0.95
0.18
14.5
10.2
u/l
30.7
25.0
0.89
335
3397
(3005322) IgE [Units/volume] in Serum or Plasma
13
149
0.87
0.13
2.5
1.3
u/ml
1020.3
235.6
0.61
13
134
(40761511) CBC panel - Blood by Automated count
354
3503
1.04
0.13
34.1
14.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
19
172
1.11
0.11
2.7
2.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
281
0.92
0.11
3.8
2.7
ml/min/173m2
55.4
60.3
—
10
107
(3009542) Hematocrit [Volume Fraction] of Blood
290
2937
0.97
0.11
38.7
15.9
%
34.6
39.1
4.98
150
1874
(36660697) Celiac disease serology panel - Serum
21
228
0.92
0.10
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
67
1.05
0.08
2.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
82
0.85
0.07
2.7
2.5
—
—
—
0
0
(4034850)
9
105
0.85
0.06
12.2
10.9
—
—
—
0
0
(3035941) MCH [Entitic mass]
370
3718
0.98
0.05
49.2
21.8
pg
30.2
30.4
0.99
364
3631
(3000963) Hemoglobin [Mass/volume] in Blood
370
3718
0.98
0.05
49.9
22.0
g/l
125.7
133.9
18.31
364
3626
(3026361) Erythrocytes [#/volume] in Blood
370
3718
0.98
0.05
49.4
21.9
e12/l
4.2
4.4
14.67
360
3580
(3003694) ABO and Rh group [Type] in Blood
84
823
1.03
0.05
1.4
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
370
3717
0.98
0.05
49.2
21.9
e9/l
242.8
240.5
0.25
361
3597
(3024731) MCV [Entitic volume]
370
3717
0.98
0.05
49.3
21.8
fl
91.8
91.5
0.60
364
3631
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
140
1.07
0.04
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
136
1371
0.99
0.02
3.7
5.3
ug/l
2.1
3.0
1.52
121
1199
(3010813) Leukocytes [#/volume] in Blood
371
3720
0.99
0.02
49.5
21.9
e9/l
7.8
6.9
8.75
361
3583
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
157
0.95
0.01
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
134
1.05
0.00
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
145
0.96
0.00
2.1
2.0
—
—
—
0
0
(4010399)
24
245
0.98
0.00
1.7
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
98
1.02
0.00
1.6
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
152
0.99
0.00
1.1
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
99
1.01
0.00
1.6
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
18.0
—
7.3
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
56
0.89
0.00
2.2
2.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
23.3
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
82
0.98
0.00
1.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
69
0.87
0.00
2.5
2.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPEROSMHNAT and mortality.

Females

Parameter HR [95% CI] p-value
E4_HYPEROSMHNAT 2.976 [2.48, 3.57] < 0.001
Birth year 0.994 [0.98, 1.0] 0.197

During the follow-up period (1.1.1998 — 31.12.2019), 1646 out of 2715 females with E4_HYPEROSMHNAT died.

Males

Parameter HR [95% CI] p-value
E4_HYPEROSMHNAT 4.461 [3.18, 6.26] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1063 out of 1820 males with E4_HYPEROSMHNAT died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPEROSMHNAT.

N-year risk Females Males
1 0.292% 0.98%
5 1.729% 5.517%
10 4.226% 12.168%
15 8.068% 21.54%
20 13.518% 34.209%

Relationships between endpoints

↥

Index endpoint: E4_HYPEROSMHNAT – Hyperosmolality and hypernatraemia

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data